Life must be monitored with frequent COVID-19 testing. Innova Medical Group believes students deserve a safe and engaging learning environment.
How do you keep students and staff protected and virus-free in schools as we return to on-site education?
Mass, rapid surveillance testing on students and staff is the best way to fend off outbreaks on campuses and schools. With the availability and affordability of Innova’s rapid antigen test, schools can ramp up testing and stay ahead of COVID-19. Far too many universities around the world have no testing plan or only a voluntary one with little follow up. Also, many schools rely on Polymerase Chain Reaction (PCR) testing that requires laboratory work and often 48 hours to yield results, far too long to effectively identify infectious individuals and control outbreaks. Often, these schools only test individuals that have symptoms of COVID but don’t identify asymptomatic cases, increasing the likelihood of silent spreading. On the other hand, rapid antigen testing, at least twice a week, can let students know their COVID-19 status and stop onward transmission.
Entry testing, before returning to campus, combined with regular testing might prevent or reduce coronavirus transmission. But universities and schools need guidance to conduct massive testing with tools that can quickly yield results. Communities close to universities also need to understand real-time risk. Students learn more effectively in classroom settings and they, as well as teachers and staff, must feel safe enough to return to campus.
With Innova’s recent success in the Operation Moonshot Liverpool pilot, the UK government plans to mass test students before they can return to campuses. The Innova SARS-CoV-2 rapid antigen test can detect viral proteins on a machine-free, lateral flow assay, in as little as 15 minutes. Especially with the higher transmissibility of the new COVID-19 variant, testing can keep schools and universities operating.